Diversity of carbapenemase producing P. aeruginosa clones suggests serious implications on clinical outcomes and resistance dissemination
METHODS: A prospective cohort of patients infected with CRP was enrolled in five tertiary-care level hospitals from Medellín between June-2012 and May-2013. All subjects were followed until clinical outcome. Clinical and microbiological information was retrieved from medical records. Carbapenemases were detected by PCR and strain typing by PFGE. Bivariate analyses were done using X2,Fisher’s exact test, risk ratios (RR).
RESULTS: During the study period 146 patients were included. Carbapenemases blaVIM and blaKPC were detected in 15.1% and 7.5% isolates, respectively. Carbapenemase (C) and non-carbapenemase (NC) producing isolates were different regarding predominant types of infections (p=0.034). MDR (resistance to ≥3 antibiotic families) was higher in C (77.4%) than in NC (27%) isolates (p<0.001). Mortality was higher in infections caused by C than NC (RR=1,47, IC95%: 0.82-2.64). A pseudo outbreak of CRP harboring blaKPCwas detected between August-2012 and January-2013 in four hospitals but PFGE revealed that isolates were genetically different.
CONCLUSIONS: In Medellín, the presence of C isolates with diverse genetic backgrounds has emerged with relevant implications in patient clinical outcomes. This situation points to antibiotic selective pressure as a driving force for resistance emergence and a high potential of carbapenemase dissemination in P. aeruginosa. Incorporating molecular epidemiology to surveillance activities should become the mainstay in order to improve understanding of emergence of resistant clones and effectively control antibiotic resistance in Colombia.